21-Jul-2022 | Facts and Factors
According to Facts and Factors, the global embolization particles market size was valued at USD 1,329.5 million in 2021 and is predicted to increase at a CAGR of 11.30% to USD 2,527.3 million by 2028. The study examines the market in terms of revenue in each of the major regions, which are classified into countries.
Embolization therapy is a non-invasive treatment that restricts blood from flowing into one or more of the blood arteries that feed abnormalities such as hypervascular tumours and arteriovenous malformations. To minimize the deformity within the tumour, embolic material is pushed into the vessels to restrict the flow of blood. The procedure of embolization is used to treat kidney cancer tumours, hepatocellular carcinoma (HCC), renal cell carcinoma (RCC), and liver cancer tumours, among other things. It has numerous advantages, including a low risk of infection during invasive surgeries, a quick recovery period, good haemorrhage control, less trauma, and so on. Interventional radiologists are in charge of this procedure.
Browse the full “Embolization Particles Market By Product (Radioembolization Spheres, Microspheres, Drug Eluting Beads, Others), By Application (Peripheral Vascular Disease, Neurology, Oncology, Urology, Others), By End-user (Hospitals, Ambulatory Centers, Clinics), and By Region - Global Industry Insights, Growth, Size, Share, Comparative Analysis, Trends, Statistical Research, Market Intelligence, and Forecast 2022 – 2028" report at https://www.fnfresearch.com/embolization-particles-market
Several industries have doubled in size as a result of the increased reliance on the market. The embolization particle industry has emerged as a very appealing and simple solution. The market for embolization particles has been extremely diverse. There are a number of emerging markets in the embolization particles industry throughout the world, like India, China, and Brazil, that are expected to grow rapidly in the coming years. The concept is gaining traction due to a variety of considerations. Innovative strategies are being used to plan and execute current corporate operations. Several variables influence the growth of the embolization particle market, including market size, global technology trends, capital investment, and so on.
Segmental Overview
The market for embolization particles is divided into four categories: Product Type, Application, End-User, and Region.
The market is divided into radioembolization spheres, microspheres, drug eluting beads, PVA particles, and Gel foam particles, and other particles based on product type segmentation. The market is divided into peripheral vascular disease, neurology, cancer, urology, and other applications. The market is divided into three types of end-users: hospitals, ambulatory centers, and clinics.
Regional Overview
The global evaluation of several embolization particle businesses, such as Asia Pacific, North America, European nations, and the rest of the worldwide countries, is being divided and analyzed. According to Geographic proximity, North America is expected to be the largest market in terms of profit contribution accounting for the rising adoption of cloud-based services by production systems and distribution channels. Furthermore, owing to enhanced investment, Asia Pacific countries are expected to develop rapidly in the market. In contrast, demand has increased in key developing countries. For example, in various Asia-Pacific areas, India and China are estimated to drive an increase in embolization particle demand.
Report Scope
Report Attribute |
Details |
Market Size in 2021 |
USD 1,329.5 Million |
Projected Market Size in 2028 |
USD 2,527.3 Million |
CAGR Growth Rate |
11.30% CAGR |
Base Year |
2021 |
Forecast Years |
2022-2028 |
Key Market Players |
AON Plc, Arctic Shores Limited, Aspiring Minds, Birkman International, Inc., Development Dimensions International, Inc., HireVue, Korn Ferry, IBM Corporation, Mettl Online Assessment, SHL, and Others |
Key Segment |
By Product Type, Application, End-User, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Competitive Landscape
The report contains qualitative and quantitative research on the global Embolization Particles Market, as well as detailed insights and development strategies employed by the leading competitors. The report also provides an in-depth analysis of the market's main competitors, as well as information on their competitiveness. The research also identifies and analyses important business strategies used by these main market players, such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts. The study examines, among other things, each company's global presence, competitors, service offers, and standards.
Some of the major companies operating in the embolization particles market are Abbott Laboratories, Boston Scientific Corporation, BTG plc, Cook Medical, Inc., Edwards Lifesciences, Johnson & Johnson, Pfizer, Inc., Sirtex Medical Limited, St. Jude Medical, Inc., Terumo Corporation, and others.
The Global Embolization Particles Market is segmented as follows:
By Product
- Radioembolization Spheres
- Microspheres
- Drug Eluting Beads
- Others
By Application
- Peripheral Vascular Disease
- Neurology
- Oncology
- Urology
- Others
By End-user
- Hospitals
- Ambulatory Centers
- Clinics
By Region
- North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
